Regeneron Pharmaceuticals Inc (REGN)

574.61
-8.52(-1.46%)
After Hours
573.36
-1.25(-0.22%)
- Real-time Data
  • Volume:
    775,642
  • Bid/Ask:
    567.64/586.20
  • Day's Range:
    572.91 - 583.28

REGN Comments

What is your sentiment on Regeneron Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

All Comments

(106)
  • As far as i can see, insiders are exercising cheap options to sell immediately for good profit; but there’s no one of the board buying at the market, to give some confidence on the company; to myself it’s a pity of time and wasted capital stuck on this
    0
    • possibly acquiring Inovio?
      0
      • They shouldn’t; then the 500$ line will be lost forever
        1
    • 490.08
      1
      • 483.75
        0
        • hello
          0
          • 100
            0
            • hello
              0
              • I smell billions
                0
                • hi
                  0
                  • 700
                    0
                    • 500
                      0
                      • topped just above 500 and down back to 480, what's next?
                        0
                        • earnings tomorrow ;)
                          0
                      • I bought @470 I'll comeback to discuss more at @600 :)))
                        0
                        • Give the anti-corona spray from marinomed-biotech some VC and invest in a pharma company which is heading to the moon:https://www.investing.com/equities/marinomed-biotech-agStudies are proving that the patented method of marinomed prevents infection with all Corona varietis including mutants. It also prevents other virus infections. They have many patents.  Do some good and get rich
                          0
                          • digipharm going to be big check it out
                            0
                            • Quick buy call on SNDX pharma with 20% upside cap today..17.5 call option target 5$
                              0
                              • EPS forecast is going to 'double' to 16 !! (august earnings) . go go go
                                0
                                • Going up !! Target 640!
                                  0
                                  • Whwre you see that
                                    1
                                  • earnings, analists, news, ... read read read
                                    0
                                • Clinical phae 3 data was just released, showing that 50% dose of REG-COV is also effective, even 12.5% works... This should significantly increase the revenue they can tap from the antibody cure, now that the numbers are surging all over Europe
                                  0
                                  • Do they pay dividends?
                                    1
                                    • nopp
                                      0
                                  • Heading south, ey?
                                    0
                                    • did we hit bottom yet?
                                      2
                                      • why is it going down for weeks ?
                                        0
                                        • ARKG is buying REGN now to hedge against a correction and sell them to buy more growth stock when that happens. However the valuation is indeed quite attractive.
                                          0
                                      • why is it going down fir weeks ?
                                        0
                                        • 477$ is good time to enter IMO.
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.